Outsourcing

While all market signs are pointing up, memories of past setbacks may discourage from expanding capacity.

The addition of a new manufacturing line at Lonza’s Portsmouth, NH site enables Alexion to add dedicated product supply for 10 years.

Gil Roth, Founder and President of the Pharma & Biopharma Outsourcing Association speaks with Pharmaceutical Technology.

Jim Miller, President of PharmSource, speaks with Pharmaceutical Technology.

Jim Miller, President of PharmSource, spoke with Pharmaceutical Technology about working with CMOs and CDMOs.

The 12th Annual Report and Survey of Biomanufacturing is now available.

SGS Life Science Services expands cGMP chemistry and biotechnology testing facilities in Shanghai.

A new SGS Life Science Services laboratory outside Paris is designed for bio/pharmaceutical quality control testing.

Presenters at IVT's Microbiology Week discussed best practices and recent guidance publications for microbial control in sterile and non-sterile pharmaceutical processes.

Catalent’s Singapore facility is awarded GMP certification.

Vetter completes on-site expansion activities of visual inspection and in-process control at Chicago facility.

Huber Kältemaschinenbau will be exhibiting temperature control solutions for the research laboratory and process industry at ACHEMA 2015.

Porvair has developed a 2-ml 96 round-well deep-well plate that enables scientists to use the full 2.00 ml well capacity.

Biopharma companies on both sides of the Atlantic ship more of their assay testing to outside service providers.

ProMetic Life Sciences will use manufacturing and plasma fractionation processes at Emergent BioSolutions’ Winnipeg, Canada facility.

Clinical supplies facility in Frankfurt, Germany will triple Theorem Clinical Research’s current clinical supplies capacity.

Grand River Aseptic Manufacturing named one of Michigan 50 Companies to watch.

This new pharmaceutical stability storage facility will enable the company to expand its analytical and formulation offerings to the pharmaceutical and biotech industries.

EMA confirms its recommendation to suspend medicines approved based on GVK Biosciences studies.

The use of disposables requires careful consideration and planning.

FDA issues a Form 483 following inspection of Impax Laboratories' Hayward, CA facility.

Capsugel extends inhaled biotherapeutics delivery capability to Phase 2 clinical trials.

While the United States and Europe still dominate, CMOs and CROs based in emerging markets continue to capture market share.

The rapid testing of biologic raw materials can lead to greater efficiency.

Pharmaceutical companies should take into consideration intellectual property protection when outsourcing the packaging of their products.